
ASTH P/E Ratio
P/E Ratio as of Dec 3, 2025: 121.16
Average111.11
Median118.42
Minimum64.12
Maximum132.65
121.16
57.25 (89.58%)past month
The P/E ratio for ASTH is 121.16 as of Dec 3, 2025. This represents a increase of 164.08% compared to its 12-month average P/E ratio of 45.88. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Astrana Health Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Astrana Health Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Astrana Health Inc to industry peers.
Astrana Health Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Astrana Health Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Astrana Health Inc to industry peers.
ASTH P/E Ratio Insights
See Astrana Health Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in ASTH
Order type
Buy in
Order amount
Est. shares
0 shares
ASTH P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Dec 1, 2025 | $23.18 | 122.00 |
| Nov 3, 2025 | $32.99 | 63.91 |
| Oct 1, 2025 | $28.16 | 54.55 |
| Sep 2, 2025 | $31.88 | 61.76 |
| Aug 1, 2025 | $21.57 | 29.74 |
| Jul 1, 2025 | $25.06 | 34.55 |
| Jun 2, 2025 | $24.50 | 33.78 |
| May 1, 2025 | $31.44 | 34.96 |
| Apr 1, 2025 | $29.86 | 33.20 |
| Mar 3, 2025 | $26.48 | 29.61 |
| Feb 3, 2025 | $36.28 | 27.82 |
| Jan 2, 2025 | $32.20 | 24.69 |
ASTH End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | 121.16 | +401.28% |
| 2024 | 24.17 | -38.44% |
| 2023 | 39.26 | +88.57% |
| 2022 | 20.82 | -54.13% |
| 2021 | 45.39 | +143.51% |
| 2020 | 18.64 | — |
FAQs About Astrana Health Inc (ASTH) P/E ratio
The latest P/E ratio of ASTH is 121.16, as of Dec 3, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Astrana Health Inc’s last 12-month average P/E ratio is 45.88, compared to its current P/E ratio of 121.16. This reflects a increase of 164.08%.
Astrana Health Inc’s current P/E ratio of 121.16 is higher than its last 12-month average P/E of 45.88. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Astrana Health Inc’s average P/E ratio over the last 3 years is 37.36. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Astrana Health Inc’s average P/E ratio over the last 5 years is 36.2. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.